✦ LIBER ✦

Safety, tolerability and clinical efficacy of ultra-rush sublingual immunotherapy among patients suffering from allergic rhinitis

✍ Scribed by Balaji, R.; Parasuramalu, B.G.; Chandregowda, B.V.; Gangaboraiah,

Book ID: 122479880
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 407 KB
Volume: 42
Category: Article
ISSN: 0301-0546
DOI: 10.1016/j.aller.2012.12.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and tolerability of ultra-Rush (2

Safety and tolerability of ultra-Rush (20 minutes) sublingual immunotherapy in patients with allergic rhinitis and/or asthma

✍ E. Gammeri; A. Arena; R. D’anneo; S. La Grutta 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Safety and Tolerability of Ultra-Rush (2

Safety and Tolerability of Ultra-Rush (20 minutes) Sublingual Immunotherapy in Patients with Allergic Rhinitis and/or Asthma

✍ E. Gammeri; A. Arena; R. D’Anneo; S. La Grutta 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Safety and tolerability of ultra-rush (2

Safety and tolerability of ultra-rush (20 minutes) allergoid sublingual immunotherapy in patients with allergic rhinitis and/or asthma*1

✍ GAMMERI, E 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 25 KB

Efficacy and safety of high-doses sublin

Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen

✍ I. Stelmach; J. Kaczmarek-Woźniak; P. Majak; M. Olszowiec-Chlebna; J. Jerzynska 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Efficacy and safety of 5-grass pollen su

Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis

✍ H-J. Malling; A. Montagut; M. Melac; G. Patriarca; P. Panzner; E. Seberova; A. D 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

## Summary ## Background The optimal dose of grass pollen tablets for sublingual immunotherapy (SLIT) in allergic rhinoconjunctivitis patients was previously established in a multinational, randomized, double-blind, placebo-controlled study in 628 adults. Patients were randomized to receive once-d

Evaluation of safety and clinical effica

Evaluation of safety and clinical efficacy of higher dose immunotherapy with AIC (immunostimulatory DNA conjugated with Amb a 1) in patients with ragweed-induced seasonal allergic rhinitis (SAR)

✍ Vaishnav, A.R.; Whaley, S.B.; Hamilton, R.; Levitt, D.; Creticos, P.S. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 31 KB